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Abstract Protective antigen (PA) is the central receptor bind-
ing component of anthrax toxin, which translocates catalytic
components of the toxin into the cytosol of mammalian cells.
Ever since the crystal structure of PA was solved, there have
been speculations regarding the possible role of calcium ions
present in domain I of the protein. We have carried out a sys-
tematic study to elucidate the e¡ect of calcium removal on the
structural stability of PA using various optical spectroscopic
techniques, limited proteolysis and mutational analysis. Urea
denaturation studies clearly suggest that the unfolding pathway
of the protein follows a non-two state transition with apo-PA
being an intermediate species, whereas the folding pathway
shows that calcium ions may be critical for the initial protein
assembly.
$ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The native conformation of a protein is maintained by non-
covalent interactions and even a small or a localized structural
change can a¡ect the global protein stability by switching it to
random coil state [1^4]. In this regard, metal binding proteins
serve as good model systems for studying structure^stability
relationships as the unfolded states of both the ion-bound and
the ion-free (apo) forms are the same in principle [5]. Among
the metalloproteins, the calcium binding proteins form a ma-
jor subclass and perform variegated biological functions [6^8].
In many cases, it has been shown that conformational changes
induced by calcium binding are functionally important, en-
hance structural stability and decrease the structural pertur-
bations relative to the ion-free form [9^11].
Protective antigen (PA), the central component of the an-
thrax toxin, is a tetra-domain protein that delivers catalytic
moieties, viz. edema factor (EF) and lethal factor (LF), into
the cytosol of mammalian cells [12]. During the intoxication
process of anthrax toxin, PA is cleaved by cell surface pro-
teases like furin and in vitro by trypsin at the 164RKKR167 site
present in domain I, to generate a 63 kDa C-terminal frag-
ment (PA63) which actively participates in the subsequent
steps [13,14]. The cleavage has been shown to be very speci¢c
and deletion of this site abolishes the LF binding activity of
PA [14]. X-ray di¡raction data of PA revealed the presence of
a pair of adjacent calcium ions coordinated to a variant of the
EF hand motif in domain I [15]. A recent report showed that
these ions are tightly bound to PA as indicated by their slow
exchange rate with labeled Ca2þ ions [16]. Furthermore, the
exchange rate was found to be enhanced in the case of PA63
heptamer but there was a reduction in this rate on binding of
LF to the heptamer, re£ecting ligand (LF)-dependent stabili-
zation of domain I [16]. But surprisingly, detailed analysis of
structural transitions and biochemical properties of protein in
the Ca2þ ion-bound and unbound state is not available in the
literature. In the present paper, the role of calcium ions in
providing structural stability to PA was investigated by pro-
teolysis, spectroscopic analyses, denaturation studies and mu-
tational analyses. We show that apo-PA appears to be an
intermediate in the unfolding pathway of the protein, while
binding of calcium and folding of PA may occur as a con-
certed mechanism.
2. Materials and methods
2.1. Materials
Bacterial culture media were purchased from Difco Laboratories,
USA. The enzymes and chemicals for DNA manipulations were ob-
tained from New England BioLabs, USA. All other chemicals were
obtained from Sigma Chemicals (St. Louis, MO, USA). Urea was re-
crystallized with ethanol before the experiments.
2.2. Puri¢cation of PA and preparation of apo-PA
PA was puri¢ed from culture supernatant of Bacillus anthracis
BH441 as described previously [13]. For preparation of apo-PA, PA
(2.0 mg/ml) was taken in 10 mM HEPES, pH 7.2, 100 mM NaCl
(bu¡er A), incubated with 3 M urea and 10 mM EGTA for 3 h at
28‡C and then dialyzed extensively against bu¡er A at 4‡C. Bu¡er A
used for studies was treated with Chelex-100 resin to remove any free
calcium. The removal of calcium from PA was con¢rmed by analyzing
the samples on atomic absorption spectrophotometer (GBC Scienti¢c
Equipment, model GBC 932AA).
The protein concentration was determined by the method of Brad-
ford with bovine serum albumin as a standard.
2.3. Fluorescence studies
The samples (0.65 WM) were excited at 290 nm and £uorescence
emission spectra were recorded from 300 to 400 nm on a spectro£u-
orometer (Jobin Yvon FluoroMax-3) in a 10 mm path length quartz
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cell at 25‡C. Excitation and emission band passes were kept at 10 nm.
The baseline was corrected with bu¡er alone prior to every run.
2.4. Circular dichroism (CD) studies
CD measurements were carried out on a Jasco J-715 spectropo-
larimeter at 25‡C. The protein concentration was kept at 0.65 and
18 WM for far- and near-UV CD measurements respectively and spec-
tra were corrected for baseline with bu¡er alone.
2.5. Urea denaturation studies
PA and apo-PA (0.65 WM) were incubated with di¡erent concen-
trations of urea for 1 h at 25‡C before taking the measurements. Each
concentration of urea was taken as appropriate controls.
2.6. Data analysis
A three state model of unfolding was used for biphasic urea dena-
turation curve. The equation describing a three state denaturation
transition [17] is:
Fapp ¼
exp½ð3vGH2OIU þmIUcÞ=RT U½Z þ exp½ð3vGH2ONI þmNIcÞ=RT 
1þ exp½ð3vGH2OIU þmIUcÞ=RT U½1þ exp½ð3vGH2ONI þmNIcÞ=RT 
ð1Þ
where Fapp is the apparent fraction of folded protein, Z normalizes the
optical properties of the intermediate to those of the native and un-
folded protein forms and vGH2ONI and vG
H2O
IU are the free energy
changes in the absence of denaturant for the native (N) to intermedi-
ate (I) and intermediate to unfolded (U) transitions, respectively, mNI
and mIU are cooperativity parameters of the native to intermediate
and intermediate to unfolded transitions, respectively, and c is the
denaturant concentration. Fapp values were calculated using the equa-
tion:
Fapp ¼ ðyi3yUÞ=ðyN3yUÞ
where yi is the observed value of the spectroscopic parameter at de-
naturant concentration i and yU and yN are the values of the unfolded
and native forms of the protein, respectively. Non-linear least squares
¢tting of Eq. 1 to urea denaturation curve was performed using the
program SPSS 11.0.
2.7. Mutagenesis of PA gene and their expression
Mutations in the PA gene were introduced using appropriate mu-
tagenic overlapping primers in the previously described plasmids
pYS5 or pMS1 [18,19]. PA mutants were expressed either in a non-
toxigenic B. anthracis BH441 strain or in Escherichia coli BL21 cells.
PA and mutated PA genes were subcloned in an expression plasmid
containing 6UHis tag and T7 promoter. Coupled in vitro transcrip-
tion and translation was carried out in RTS-500 instrument using
E. coli circular template kit (Roche Diagnostics, Germany). The re-
action mixture was prepared according to the manufacturer’s instruc-
tions and 15 Wg plasmid DNA was used for a reaction of V20 h. At
the end, aliquots were stored at 320‡C until further use.
2.8. Cell culture and cytotoxicity assay
The J774A.1 macrophage cell line was maintained in Dulbecco’s
modi¢ed Eagle’s medium supplemented with 10% fetal calf serum
and 50 Wg/ml gentamicin. Proteins were assayed for toxicity in the
macrophage lysis assay as described previously [20].
Fig. 1. A: Fluorescence emission spectra. Emission spectra of PA and apo-PA were recorded as described in Section 2. Arrow indicates emis-
sion maxima of samples. Each spectrum is an average of four scans. B,C: CD spectra. Far-UV CD (B) and near-UV CD (C) spectra of PA
and apo-PA were recorded as described in Section 2. A path length of 10 mm was used and the spectra were averaged over six scans.
FEBS 27832 5-11-03
P.K. Gupta et al./FEBS Letters 554 (2003) 505^510506
3. Results and discussion
3.1. Spectral properties
Comparison of the spectroscopic properties of PA and apo-
PA revealed that the removal of Ca2þ ions from PA has a
profound e¡ect on its molecular conformation. PA had a
tryptophan £uorescence with an emission Vmax of 335 nm,
suggesting that the tryptophan moieties are buried in the hy-
drophobic core of PA. In comparison, apo-PA had only 40%
of the £uorescence intensity of PA with an 11 nm red shift in
emission maximum indicating the exposure of tryptophan res-
idues to the bulk solvent (Fig. 1A) [21].
The far-UV CD spectrum of PA has two minima at 208 and
220 nm with the 208 nm band having greater intensity (Fig.
1B) indicative of a classical K+L protein [22]. In contrast to
this, apo-PA showed a minimum at 205 nm suggesting an
increased randomness in the structure. Comparison of near-
UV CD spectra revealed a substantial loss in the tertiary
structure of PA on removal of calcium (Fig. 1C) [23]. Fur-
thermore, it was observed that the structure of the protein was
restored when apo-PA was supplemented with external Ca2þ,
whereas Mg2þ, which is highly abundant in vivo, restored it to
only 60^70% as monitored by spectroscopic methods (data
not shown). These results suggest that the presence of calcium
ions in PA is of utmost importance for maintaining its overall
conformation.
3.2. Urea denaturation studies
To elucidate the thermodynamic stability, we carried out
equilibrium unfolding studies on PA and apo-PA using urea
as the denaturant.
Far-UV CD studies on urea-induced unfolding of PA were
carried out to investigate the changes in its secondary struc-
ture with increasing concentration of urea. Up to a urea con-
centration of 1.0 M, there was a slight increase in the elliptic-
ity at 222 nm of both apo- and native PA (Fig. 2A) probably
due to slight compactness in the structure as reported earlier
for many other proteins [24^26]. But the ellipticity at 222 nm
was completely lost as the urea concentration reached 6 M.
The Cm value (concentration of urea at which 50% population
is unfolded) for unfolding of PA was V3.6 M.
The alteration in microenvironment of tryptophan residues
on removal of calcium from PA was monitored by studying
changes in tryptophan £uorescence intensity and emission
maximum (Vmax) as a function of denaturant concentration.
Between 0 and 2 M urea, there was a substantial fall in the
£uorescence intensity of PA (data not shown) and an increase
in the Vmax emission from 335 nm to 347 nm (Fig. 2B). On
further increasing the denaturant concentration, native pro-
tein completely unfolded at 6 M urea with a shift in emission
Vmax to 356 nm. Furthermore, PA shows a typical biphasic
curve suggesting the presence of an intermediate around 2 M
urea concentration (Fig. 2B). This fact was recon¢rmed when
the denaturation curves of PA as monitored by tryptophan
£uorescence and CD were found to be non-coincidental (Fig.
2C) further suggesting a ‘non-two state transition’ for PA as
reported earlier for other proteins [27^29].
The denaturation midpoint of the ¢rst phase occurs near
1.3 M urea, while the second phase has a midpoint near 4.45
M urea (Fig. 2B). The denaturation curve was ¢tted to a three
state model as described in Section 2. On the basis of this ¢t
(Fig. 2D), the following values ( T S.E.M.) were obtained for:
Fig. 2. Urea denaturation pro¢le. Samples were incubated with increasing concentration of urea for 1 h prior to the spectral studies. Far-UV
CD (ellipticity at 222 nm) (A) and Vmax emission (B) of PA and apo-PA are presented with increasing concentrations of urea. Superimposition
of urea-induced changes in £uorescence and far-UV CD of PA is shown in C. D shows the apparent fraction of unfolded protein (Fapp) with
varying concentrations of denaturant after performing non-linear least squares ¢tting of Eq. 1 to the urea denaturation curve using the pro-
gram SPSS 11.0. For panels A and C, the value at 0 M urea concentration is represented as 1, i.e. folded state.
FEBS 27832 5-11-03
P.K. Gupta et al./FEBS Letters 554 (2003) 505^510 507
vGH2ONI , 32.32T 0.219 kcal/mol; mNI, 1.819T 0.211 kcal/mol
2 ;
vGH2OIU , 34.05T 0.730 kcal/mol; mIU, 0.877T 0.156 kcal/mol
2,
and Z, 0.371T 0.025. The values of calculated free energy
changes suggest that the intermediate state is energetically
more similar to the native state than the unfolded state.
Closer inspection of £uorescence and far-UV CD spectra of
2 M urea-treated PA revealed distinct similarities with apo-PA
(Fig. 2A,B), indicating that apo-PA might be an intermediate
in the unfolding pathway of PA. The experimental evidence
comes from the fact that electrophoretic analysis of tryptic
digest of 2 M urea-treated PA behaved in a similar fashion
as apo-PA with the loss of a 63 kDa band and appearance of
30 kDa and 31 kDa bands along with 20 kDa (Fig. 3A,B). A
similar observation for apo-PA has been reported recently by
Gao-Sheridan et al. [16]. These two new polypeptides (30 and
31 kDa) were also susceptible to proteolysis and degraded on
prolonged incubation of apo-PA with trypsin over a period of
45 min while PA63 was stable within this period (Fig. 3B). To
rule out the possibility that increased proteolysis is a conse-
quence of urea used during preparation of apo-PA, PA
treated with urea and dialyzed against bu¡er A was used as
a control which behaved in a similar fashion as PA (data not
shown).
3.3. Mutational analysis
The crystal structure of PA reveals the presence of a pair of
octahedral complexes composed of eight amino acid residues
and a water molecule on domain I chelating two calcium ions
[15]. In order to understand the folding behavior of calcium-
depleted PA we generated single, double and triple mutants by
replacing the amino acids ligating calcium ion with alanine
(Table 1). The PA genes carrying the mutation were cloned
and expressed in a bacillus-based vector (plasmid pYS5) and
an E. coli-based vector (plasmid pMS1) as described previ-
ously [18,19]. The expressed mutant proteins were found to
be highly unstable and degraded during the puri¢cation pro-
cess. To circumvent this, attempts were made to express the
mutant proteins by coupling in vitro transcription and trans-
lation in a cell-free Rapid Translation System (RTS 500). The
RTS system was initially standardized for native PA and the
yield of puri¢ed PA was 30^40 Wg from a 1 ml reaction mix-
ture. The mutant proteins were also expressed under similar
conditions and expression was found to be comparable to
native PA as shown by Western blot of the reaction mixture
(Fig. 4A). Strangely, even in the presence of a cocktail of
protease inhibitors extensive degradation of mutant proteins
hampered our attempts to purify them. This implies the role
of the Ca2þ binding region of domain I in protein assembly
and initial folding.
3.4. Cytotoxicity assay
The biological activities of apo-PA and RTS-expressed mu-
tant PA proteins in combination with LF (1.5 Wg/ml) were
determined in a cytotoxicity assay using J774A.1 macrophages
as described previously [20]. The cytotoxicity measurements
could not be done for apo-PA, as the cell culture medium
Fig. 3. Trypsin susceptibility analysis. PA, apo-PA and PA pre-incu-
bated with 2 M urea (1 mg/ml) were treated with trypsin and ana-
lyzed on a 10% sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE) followed by staining with Coomassie brilliant
blue R. A: Lane 1: PA; lane 2: PA treated with trypsin for 20
min; lanes 3 and 4: PA preincubated with 1 and 2 M urea respec-
tively followed by trypsin treatment for 20 min. B: Lane 1: PA;
lanes 2 and 3: PA treated with trypsin for 20 and 45 min respec-
tively; lane 4: apo-PA; lanes 5 and 6: apo-PA treated with trypsin
for 20 and 45 min respectively.
Table 1
Description of PA mutant produced in RTS and their cytotoxicity
on J774A.1 cells
Mutant Cytotoxicity (LC50) (ng/ml)
PA V450
D177A s 1220
D179A s 1250
D181A s 1170
I183A s 1200
E188A s 1220
D235A s 1150
S222A and K225A s 1210
D179A, D181A and E188A s 1260
The residues involved in calcium binding were replaced with alanine
(individually or in combination) and produced in a cell-free system.
For cytotoxicity experiments, cells were incubated with increasing
amounts (volume of reaction mixture) in combination with LF (1.5
Wg/ml). After 4 h, 0.5 mg/ml MTT was added to the cells and incu-
bated for 45 min. LC50 is the amount required to kill 50% of cells.
Each value represents the average of three di¡erent experiments
done in triplicate.
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was rich in calcium and would readily convert apo-PA to PA.
Calcium-depleted media could not be used as the presence of
extracellular calcium has been shown to be essential for the
activity of lethal toxin [30]. The cytotoxicity assay on mutant
proteins was carried out with crude RTS mixture as attempts
to purify them were not successful as mentioned above. Den-
sitometry and Western blot analysis indicated that V30^40%
of the crude protein extract was the intact 83 kDa form (data
not shown). Crude RTS mixture containing native PA showed
50% killing of J774A.1 cells at 15 Wl/ml (V450 ng PA) in
combination with LF. However, mutant proteins were found
to be non-toxic at measurable concentrations (Fig. 4B). Crude
mixture above 80 Wl/ml of cell culture medium started showing
toxicity even in the absence of LF; therefore, it was not pos-
sible to test the potency of mutant proteins beyond this con-
centration. The lack of toxicity of PA mutants can be attrib-
uted either to its unavailability due to rapid degradation or to
defects in its ability to perform various steps of cytotoxicity.
Experiments to probe the exact nature of the defect such as
receptor binding or cleavage were not possible due to the
unavailability of puri¢ed proteins. These results imply that
the amino acids ligating calcium ions play a major role in
providing structural stability to PA and loss in the cytotox-
icity of mutant proteins may be due to their inability to bind
calcium.
3.5. Conclusion
Our study shows that the removal of calcium ions from PA
leads to global conformational changes and a¡ects protein
stability as revealed by the optical spectroscopic properties
and limited proteolysis pro¢les of PA and apo-PA. Mutation-
al studies suggested the critical role of the Ca2þ binding region
of domain I in protein assembly and initial folding indicating
that the protein folding and binding of calcium ions may
follow a concerted mechanism or may have unstable inter-
mediates. In contrast, apo-PA was relatively stable as com-
pared to mutant proteins, which may be due to intra- and
intermolecular interactions that come into play once the pro-
tein is in the folded state [31]. Furthermore, urea denaturation
studies revealed that apo-PA is an intermediate species in the
unfolding pathway of PA and energetically it is more similar
to the native folded state of PA than the unfolded state. Thus,
the presence of calcium ions in PA is quite imperative for
initial folding of PA to its proper conformation, which is par-
tially maintained even on stripping o¡ the calcium ions.
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